After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

35 trades

Disclosure transactions for Scribe Therapeutics, Inc.
Reporting person Filed Transaction Transaction value Source Actions
Ah Bio Fund Ii, L.P. 10% owner Jul 29, 2026 2-day lag Conversion Jul 27, 2026 $0 Filed shares x price SEC Form 4 View filing
Ah Bio Fund Ii, L.P. 10% owner Jul 29, 2026 2-day lag Conversion Jul 27, 2026 $0 Filed shares x price SEC Form 4 View filing
Ah Bio Fund Ii, L.P. 10% owner Jul 29, 2026 2-day lag Conversion Jul 27, 2026 Not reported Reported range SEC Form 4 View filing
Ah Bio Fund Ii, L.P. 10% owner Jul 29, 2026 2-day lag Buy Jul 27, 2026 $5M Filed shares x price SEC Form 4 View filing
Ah Bio Fund Ii, L.P. 10% owner Jul 29, 2026 2-day lag Conversion Jul 27, 2026 Not reported Reported range SEC Form 4 View filing
Gordon Carl L Director Jul 29, 2026 2-day lag Conversion Jul 27, 2026 Not reported Reported range SEC Form 4 View filing
Gordon Carl L Director Jul 29, 2026 2-day lag Buy Jul 27, 2026 $15M Filed shares x price SEC Form 4 View filing
Gordon Carl L Director Jul 29, 2026 2-day lag Conversion Jul 27, 2026 $0 Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc Director Jul 29, 2026 2-day lag Conversion Jul 27, 2026 $0 Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc Director Jul 29, 2026 2-day lag Buy Jul 27, 2026 $15M Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc Director Jul 29, 2026 2-day lag Conversion Jul 27, 2026 Not reported Reported range SEC Form 4 View filing
Doudna Jennifer A 10% owner Jul 29, 2026 2-day lag Conversion Jul 27, 2026 Not reported Reported range SEC Form 4 View filing
Doudna Jennifer A 10% owner Jul 29, 2026 2-day lag Conversion Jul 27, 2026 Not reported Reported range SEC Form 4 View filing
Aghazadeh Behzad Director / Ten Percent Owner / ... Jul 28, 2026 Same-day filing Buy Jul 28, 2026 $144.27K Filed shares x price SEC Form 4 View filing
Aghazadeh Behzad Director / Ten Percent Owner / ... Jul 28, 2026 4-day lag Buy Jul 24, 2026 $1.12M Filed shares x price SEC Form 4 View filing
Aghazadeh Behzad Director / Ten Percent Owner / ... Jul 28, 2026 4-day lag Buy Jul 24, 2026 $35M Filed shares x price SEC Form 4 View filing
Staahl Brett 10% owner Jul 28, 2026 5-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Staahl Brett 10% owner Jul 28, 2026 5-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Staahl Brett 10% owner Jul 28, 2026 137-day lag Award Mar 13, 2026 $0 Filed shares x price SEC Form 4 View filing
Lucas Svetlana Chief Business Officer Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Lucas Svetlana Chief Business Officer Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Lucas Svetlana Chief Business Officer Jul 27, 2026 4-day lag Buy Jul 23, 2026 $45K Filed shares x price SEC Form 4 View filing
Lucas Svetlana Chief Business Officer Jul 27, 2026 136-day lag Award Mar 13, 2026 $0 Filed shares x price SEC Form 4 View filing
Oakes Benjamin L. President, CEO Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Oakes Benjamin L. President, CEO Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Oakes Benjamin L. President, CEO Jul 27, 2026 136-day lag Award Mar 13, 2026 $0 Filed shares x price SEC Form 4 View filing
Gordon Carl L Director Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Watson James Dean Director Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Bleharski Joshua Director Jul 27, 2026 4-day lag Award Jul 23, 2026 $0 Filed shares x price SEC Form 4 View filing
Parrot David Chief Financial Officer Jul 27, 2026 4-day lag Buy Jul 23, 2026 $20K Filed shares x price SEC Form 4 View filing
Ah Bio Fund Ii, L.P. 10% owner
Conversion
Calculated transaction value
$0 12,150,003 shares @ $0
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Ah Bio Fund Ii, L.P. 10% owner
Conversion
Calculated transaction value
$0 4,131,344 shares @ $0
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Ah Bio Fund Ii, L.P. 10% owner
Conversion
Reported value range
Not reported 2,051,742 shares
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Ah Bio Fund Ii, L.P. 10% owner
Buy
Calculated transaction value
$5M 333,333 shares @ $15
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Ah Bio Fund Ii, L.P. 10% owner
Conversion
Reported value range
Not reported 697,650 shares
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Gordon Carl L Director
Conversion
Reported value range
Not reported 348,825 shares
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Gordon Carl L Director
Buy
Calculated transaction value
$15M 1,000,000 shares @ $15
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Gordon Carl L Director
Conversion
Calculated transaction value
$0 2,065,672 shares @ $0
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Orbimed Advisors Llc Director
Conversion
Calculated transaction value
$0 2,065,672 shares @ $0
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Orbimed Advisors Llc Director
Buy
Calculated transaction value
$15M 1,000,000 shares @ $15
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Orbimed Advisors Llc Director
Conversion
Reported value range
Not reported 348,825 shares
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Doudna Jennifer A 10% owner
Conversion
Reported value range
Not reported 74,088 shares
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Doudna Jennifer A 10% owner
Conversion
Reported value range
Not reported 12,511 shares
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Aghazadeh Behzad Director / Ten Percent Owner / Other
Buy
Calculated transaction value
$144.27K 7,905 shares @ $18.25
Traded
Jul 28, 2026
Filed
Jul 28, 2026
Aghazadeh Behzad Director / Ten Percent Owner / Other
Buy
Calculated transaction value
$1.12M 50,000 shares @ $22.31
Traded
Jul 24, 2026
Filed
Jul 28, 2026
Aghazadeh Behzad Director / Ten Percent Owner / Other
Buy
Calculated transaction value
$35M 2,333,333 shares @ $15
Traded
Jul 24, 2026
Filed
Jul 28, 2026
Staahl Brett 10% owner
Award
Calculated transaction value
$0 19,385 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 28, 2026
Staahl Brett 10% owner
Award
Calculated transaction value
$0 19,385 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 28, 2026
Staahl Brett 10% owner
Award
Calculated transaction value
$0 4,755 shares @ $0
Traded
Mar 13, 2026
Filed
Jul 28, 2026
Lucas Svetlana Chief Business Officer
Award
Calculated transaction value
$0 109,426 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Lucas Svetlana Chief Business Officer
Award
Calculated transaction value
$0 109,426 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Lucas Svetlana Chief Business Officer
Buy
Calculated transaction value
$45K 3,000 shares @ $15
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Lucas Svetlana Chief Business Officer
Award
Calculated transaction value
$0 9,547 shares @ $0
Traded
Mar 13, 2026
Filed
Jul 27, 2026
Oakes Benjamin L. President, CEO
Award
Calculated transaction value
$0 429,599 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Oakes Benjamin L. President, CEO
Award
Calculated transaction value
$0 264,784 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Oakes Benjamin L. President, CEO
Award
Calculated transaction value
$0 12,969 shares @ $0
Traded
Mar 13, 2026
Filed
Jul 27, 2026
Gordon Carl L Director
Award
Calculated transaction value
$0 14,725 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Watson James Dean Director
Award
Calculated transaction value
$0 14,725 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Bleharski Joshua Director
Award
Calculated transaction value
$0 14,725 shares @ $0
Traded
Jul 23, 2026
Filed
Jul 27, 2026
Parrot David Chief Financial Officer
Buy
Calculated transaction value
$20K 1,333 shares @ $15
Traded
Jul 23, 2026
Filed
Jul 27, 2026